InvestorsHub Logo
Followers 16
Posts 3999
Boards Moderated 0
Alias Born 01/12/2004

Re: None

Wednesday, 11/01/2017 1:23:50 PM

Wednesday, November 01, 2017 1:23:50 PM

Post# of 190
More company sale speculation.

In our analysis, if there is a bidding war, a price north of $20 is possible. One analyst has a target of $30.



https://www.marketwatch.com/story/now-that-novartis-is-buying-aaa-im-zeroing-in-on-this-potential-pharma-target-2017-11-01